T-Cure Bioscience
Phase 1Develops T-cell receptor therapies for solid tumors and autoimmune diseases.
Founded
2015
Focus
Cell & Gene Therapy
About
Develops T-cell receptor therapies for solid tumors and autoimmune diseases.
Funding History
2Total raised: $35M
Series B$25MUndisclosedJun 15, 2021
Series A$10MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationLos Angeles, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile